These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 26749282

  • 1. Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.
    Karami-Tehrani F, Malek AR, Shahsavari Z, Atri M.
    Tumour Biol; 2016 Jul; 37(7):8849-56. PubMed ID: 26749282
    [Abstract] [Full Text] [Related]

  • 2. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
    Shahsavari Z, Karami-Tehrani F, Salami S, Ghasemzadeh M.
    Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M, Yamamoto M, Nakano K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H.
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
    Lin CS, Chang SC, Ou LH, Chen CM, Hsieh SS, Chung YP, King KL, Lin SL, Wei YH.
    Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
    [Abstract] [Full Text] [Related]

  • 5. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
    Kucuk U, Bayol U, Pala EE, Cumurcu S.
    Indian J Pathol Microbiol; 2013 Jun; 56(2):129-34. PubMed ID: 24056649
    [Abstract] [Full Text] [Related]

  • 6. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J.
    Clin Cancer Res; 2003 Mar; 9(3):923-30. PubMed ID: 12631589
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].
    Fang Q, Wang XF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):380-2. PubMed ID: 21354936
    [Abstract] [Full Text] [Related]

  • 8. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.
    Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
    [Abstract] [Full Text] [Related]

  • 9. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ.
    BMC Cancer; 2015 Mar 18; 15():138. PubMed ID: 25880075
    [Abstract] [Full Text] [Related]

  • 10. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.
    Am J Clin Oncol; 2013 Jun 18; 36(3):224-31. PubMed ID: 22495453
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 12. [Discordance of Estrogen Receptor,Progesterone Receptor,Cerb-B2,Ki-67 Index and P53 Expressions between Primary and Recurrent or Metastatic Sites in Breast Cancer Patients].
    Peng L, Lin JZ, Zhao DC, Zhang YN, Mao F, Sun Q.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct 30; 41(5):673-677. PubMed ID: 31699199
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.
    Khamseh ME, Sheikhi A, Shahsavari Z, Ghorbani M, Akbari H, Imani M, Panahi M, Alimohammadi A, Ameri M, Nazem S, Salimi V, Tavakoli-Yaraki M.
    BMC Endocr Disord; 2022 Jan 04; 22(1):1. PubMed ID: 34983494
    [Abstract] [Full Text] [Related]

  • 14. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A, Yagi T, Yanai A, Miyagawa Y, Enomoto Y, Murase K, Imamura M, Takatsuka Y, Sakita I, Hatada T, Miyoshi Y.
    Clin Breast Cancer; 2015 Jun 04; 15(3):204-11. PubMed ID: 25600243
    [Abstract] [Full Text] [Related]

  • 15. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, Louvrou AN, Ambela C, Koutsikos J, Lazaris D, Christodoulidou JK, Sotiropoulou MG, Melissinou MJ, Perperoglou A, Tsiouris S, Zerva CJ.
    Breast Cancer Res; 2004 Jun 04; 6(2):R56-62. PubMed ID: 14979918
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F, Noguchi S.
    Cancer; 2000 Oct 15; 89(8):1732-8. PubMed ID: 11042568
    [Abstract] [Full Text] [Related]

  • 17. Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.
    Song B, Wang L, Zhang Y, Li N, Dai H, Xu H, Cai H, Yan J.
    Cancer Biother Radiopharm; 2019 Mar 15; 34(2):85-90. PubMed ID: 30585764
    [Abstract] [Full Text] [Related]

  • 18. The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast.
    Reyes C, Nadji M.
    Appl Immunohistochem Mol Morphol; 2015 Oct 15; 23(9):624-7. PubMed ID: 25710588
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 20. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study.
    Francis IM, Alath P, George SS, Jaragh M, Al Jassar A, Kapila K.
    Diagn Cytopathol; 2016 Dec 15; 44(12):980-986. PubMed ID: 27666130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.